Wereport a case of primary biliary cirrhosis (PBC) complicated by slowly progressive insulin-dependent diabetes mellitus (SPIDDM). A 67-year-old woman was diagnosed as having PBCbased on clinical manifestations and a positive result of anti-mitochondrial antibody.
Introduction
Primary biliary cirrhosis (PBC) is associated with profound immunological disturbance which has been implicated in bile duct destruction (1). This disease is increasingly recognized as a systemic disorder associated with various autoimmunediseases such as systemic lupus erythematosus (2), autoimmune thyroiditis (3) and sicca syndrome (4).
However, it is extremely rare for PBCto be complicated by slowly progressive insulin-dependent diabetes mellitus (SPIDDM). We report a patient who presented with SPIDDM and was coincidentally found to have PBC.
Case Report
A 67-year-old womanpatient had been followed at our outpatient department for diabetes mellitus (DM)and non-Bnon-C liver cirrhosis for 7 years. She had no significant past history except for her blindness due to infectious disease at the age of 3 years old. She had no family history of DMor liver disease. The diagnosis of liver cirrhosis was made when hematoemesis due to esophageal variceal rupture was treated with endoscopic injection sclerotherapy (EIS) and endoscopic variceal ligation (EVL) therapy in 1996. At that time, she was also diagnosed as having DMfrom high fasting blood glucose (267 mg/dl) and high hemoglobin Ale level (6.8%). As her blood glucose was persistently high despite diet therapy, insulin therapy was started. However, her glucose level remained high and the dose of insulin was in- phic, bulbar conjunctiva could not be evaluated. Her breathing sound was normal and her heart beat was regular without However, the titer of antinuclear antibody (ANA)was positive (x1,280).
The titer of anti-mitochondrial antibody (AMA) was x40 (NR, <20). Furthermore, the M2component ofAMA was 129 (NR, <7). Abdominal ultrasound (US) examination demonstrated a remarkably atrophic liver and an enlarged spleen. Minimal ascites was seen in the Douglas pouch. Computed tomography (CT) showed enlargement of the lateral lobe and atrophy of the right lobe of the liver and marked splenomegaly. US and CT showed no biliary tract stones. These findings were compatible with liver cirrhosis (Fig. 2 ). As this patient had ascites, we could not examine a liver biopsy. However, based on the positivity for M2component of AMA,the elevation of biliary enzymes, no viral markers and her clinical course, we diagnosed her as symptomatic PBC. Her liver function was equivalent to Child-Pugh: grade B. The DMstatus of this patient showed insulin resistance. We thus re-evaluated the etiology of DMas follows. Insulin antibody was 5.3% (NR, <7). The titer of anti-glutamic acid decarboxylase (GAD) antibody was positive; 22.2 U/ml (NR, <1.5). Urine C-peptide was markedly reduced to 0.7 jug/day> (NR, to insulin, and autoantibodies to GADare present in 85-90 %of individuals with Type 1 DM(8).
In Type 1 DM, the degree of destruction is quite variable from slowly to rapid progressive. The rapidly progressive form is not only commonlyobserved in children, but also may occur in adults. The slowly progressive form generally occurs in adults and it is sometimes referred to as latent autoimmune diabetes in adults (LADA) (7). Kobayashi recently advocated the concept of slowly progressive IDDM (SPIDDM) (9) . The characteristics of SPIDDMinclude the following : 1) non-insulin requiring clinical phenotype at the onset of diabetes, 2) late age onset, 3) slow P-cell failure progression over several years with a persistently positive low titer of islet cell antibody (ICA) and high titer of anti-GAD antibodies, 4) autopsied pancreas pathologically demonstrates incomplete P cell loss, 5) higher family history of NIDDM, and 6) association with some genetic predisposition including HLA-DQA1 *O3O1-DQB 1*0401 and/or mitochondrial gene mutation at nucleotide pair 3,243, and a lack of association with HLA-A24.Therefore, SPIDDMis categorized as LADA (9) . Patients with SPIDDMmay have other autoimmune disorders such as Graves' disease (10),
Hashimoto's thyroiditis (ll) , and Addison's disease (12) .
Pietropaolo reported that the prevalence of anti-GAD autoantibody, which is commonin subjects with type 1 diabetes, was 5.5% in patients with PBC (13) . PBC is also frequently associated with a variety of disorders presumed to be autoimmune in nature. Collagen diseases, systemic lupus erythematosus (2), autoimmune thyroiditis (3) and sicca syndrome (4) are frequently associated.
Rare disorders associated with PBChave also been reported, including interstitial lung disease (14) , ulcerative colitis (15) 
